APA (7th ed.) Citation

Schubart, J. R., Zare, A., Fernandez-de-Castro, R. M., Figueroa, H. R., Sarel, I., Tuchman, K., . . . von Schwarz, E. (2023). Safety and outcomes analysis: Transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy. Stem Cell Research & Therapy, 14(1), 1. https://doi.org/10.1186/s13287-023-03539-6

Chicago Style (17th ed.) Citation

Schubart, Jane R., Amirhossein Zare, Roberto M. Fernandez-de-Castro, Hector Rosario Figueroa, Ina Sarel, Kelly Tuchman, Kaitlyn Esposito, Fraser C. Henderson, and Ernst von Schwarz. "Safety and Outcomes Analysis: Transcatheter Implantation of Autologous Angiogenic Cell Precursors for the Treatment of Cardiomyopathy." Stem Cell Research & Therapy 14, no. 1 (2023): 1. https://doi.org/10.1186/s13287-023-03539-6.

MLA (9th ed.) Citation

Schubart, Jane R., et al. "Safety and Outcomes Analysis: Transcatheter Implantation of Autologous Angiogenic Cell Precursors for the Treatment of Cardiomyopathy." Stem Cell Research & Therapy, vol. 14, no. 1, 2023, p. 1, https://doi.org/10.1186/s13287-023-03539-6.